Involvement of calcitonin gene-related peptide in migraine: regional cerebral blood flow and blood flow velocity in migraine patients
Open Access
- 25 April 2008
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in The Journal of Headache and Pain
- Vol. 9 (3), 151-157
- https://doi.org/10.1007/s10194-008-0036-8
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraineNeurology, 2008
- Inhibitory effect of BIBN4096BS, CGRP8–37, a CGRP antibody and an RNA‐Spiegelmer on CGRP induced vasodilatation in the perfused and non‐perfused rat middle cerebral arteryBritish Journal of Pharmacology, 2007
- No increase of calcitonin gene–related peptide in jugular blood during migraineAnnals of Neurology, 2005
- Immunohistochemical Localization of Calcitonin Receptor–Like Receptor and Receptor Activity–Modifying Proteins in the Human Cerebral VasculatureJournal of Cerebral Blood Flow & Metabolism, 2002
- Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonistBritish Journal of Pharmacology, 2000
- Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptanThe Lancet, 1991
- Vasoactive peptide release in the extracerebral circulation of humans during migraine headacheAnnals of Neurology, 1990
- Flunarizine in Prophylaxis of Childhood Migraine: A Double-Blind, Placebo-Controlled, Crossover StudyCephalalgia, 1988
- Dependency of Blood Flow Velocity in the Middle Cerebral Artery on End-Tidal Carbon Dioxide Partial Pressure—A Transcranial Ultrasound Doppler StudyJournal of Cerebral Blood Flow & Metabolism, 1984
- A Method for Calculating Regional Cerebral Blood Flow from Emission Computed Tomography of Inert Gas ConcentrationsJournal of Computer Assisted Tomography, 1981